Testing the hypothesis that matters for multiple primary endpoints

Drug Information Journal

Volumn 30, Issue 4, 1996, Pages 949-956

  Capizzi, Thomas ^a   Zhang, Ji ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Hypothesis testing; Multiple endpoints; Multiplicity adjustments; Placebo controlled trials; Statistical decision rules

Indexed keywords

CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029852244     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000410     Document Type: Review

References (7)

1. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:381-399.
2. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics. 1987; 43:487-498.
3. Tang DI, Gnecco C, Geller NL. An approximate likelihood ratio test for a normal mean vector with nonnegative components with application for clinical trials. Biometrika. 1989;76:577-583.
4. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
5. Zhang J, Shingo S, Reiss TF, Friedman BS, Capizzi TP. Statistical issues in the design and analysis of clinical trials evaluating therapy for chronic asthma. Controll Clin Trials. 1993;14:445.
6. Hughes MD, Van Essen-Zandvliet EEM, Kerstjens HAM. Issues in the design of long-term clinical trials in asthma. Drug Inf J. 1993;27:793-803.
7. National Asthma Education Program Expert Panel Report, Guidelines for the Diagnosis and Management of Asthma, National Institutes of Health, Publication No. 1991;91-3042.